ScienceTechyNews: EGLN inhibitor protects normal tissue and enables RT in mouse model of pancreatic cancer

12:03 AM
Administration of the EGLN inhibitor FG-4592 prior to ablative radiotherapy provided protection against fatal gastrointestinal bleeding and improved survival in a mouse model of unresectable pancreatic cancer.

by

Post a Comment

No comments

Subscribe to: Post Comments ( Atom )
Powered by Blogger.